AUSTRALIA S FIRST DEDICATED DEPARTMENT OF DIABETES. med.monash.edu/cecs/diabetes

Similar documents
AUSTRALIA'S ONLY DEDICATED ACADEMIC DEPARTMENT OF NEUROSCIENCE.

Type 1 Diabetes Australian Research Impact Analysis

OUR STRATEGIC PLAN

IARC A UNIQUE AGENCY. Cancer research for cancer prevention

Parkinson s Institute and Clinical Center Appoints Anthony Santiago, M.D., Neurologist and Movement Disorders Specialist as Chief Medical Officer

UC San Diego HIV Institute Creating a Future Without HIV/AIDS

WHF Salim Yusuf Emerging Leaders Programme

RMIT Chinese Medicine International Collaboration in Research and Education

Movember Netherlands. Policy Plan

Parkinson s Research and the New Centre for Brain Health at UBC. Case for Support The University of British Columbia Faculty of Medicine

Australasian Sleep Association

The Terry Fox Foundation International

at a glance

BACK TO SPINAL RESEARCH

Neurofibromatosis (NF) Center

CNRC. Children s Nutrition Research Centre Brisbane, Australia. World class research into children s nutrition

Excellence Without Exception

World Connections Committee (WCC) Report

A World Free From Cancer. BC Cancer Foundation 2011 Report to Donors

Johns Hopkins individualized Health Initiative

MADE IN MOVEMBER GETTING IT GROWN FOR INQUIRIES PLEASE CONTACT FOR MORE INFORMATION ABOUT THE ORGANIZATION VISIT MADE IN MOVEMBER 2014 PRESS KIT 2

Key Highlights continued

Thomas C. Wilmot, Sr. Judy Wilmot Linehan

Strategic Directions

MONKEY. Making a Long Term Difference in Health Care. Copyright 2016 Nutritional Therapy Association, Inc.

Strategic Direction. At The Kids Cancer Project our vision is to find a cure for kids cancer

Merkin Brain and Health Policy Innovation Program 2013

UICC Members Regional Meeting. North America & Global Collaborations

Dr Graeme Suthers: The genetic basis of cancer

Allied Health: Sustainable Integrated Health Care for all Australians

Pancreatic Cancer Research Group. University of Melbourne, Department of Surgery Austin Health Delivering World Class Innovative Research

Consultation on Australian Medical Research and Innovation Priorities for

Moorfields Eye Charity Strategy People's sight matters

University of Cincinnati Heart, Lung & Vascular Institute

The Lung Cancer Network: Collaborate to Cure

a case to support THE HEART & VASCULAR CENTER

With your help, our goal is to protect millions more against serious illness through the development of new vaccines and other preventions.

Australian Organisation Launches Large International Clinical Trials in Prostate Cancer

Multi-disciplinary approach to diabetes management for rural and remote areas

American Thyroid Association

GENETIC TECHNOLOGIES LIMITED DISEASE RISK ASSESSMENT ON A GLOBAL SCALE

Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).

What is the extent of gender bias in bioinformatics?

The M8 Alliance Declaration. World Health Summit 2016 (Version: 07/10/ :30)

The Dental Corporation Opportunity

Developing the next generation of infection and immunity leaders. The Peter Doherty Institute for Infection and Immunity

Making a Difference. Highest quality care. Education. Research. Innovation. OUR MISSION:

JOINING FORCES COLLABORATING WITH PARTNERS Annual Report

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011

DIVISION OF NEPHROLOGY & HYPERTENSION

WOLFSON FERTILITY CENTRE. Wolfson Fertility Centre

Overcoming barriers. Our strategy for

PRESS RELEASE FOR IMMEDIATE RELEASE SINGAPORE INSTITUTES COLLABORATE WITH SAMSUNG MEDICAL CENTER TO IMPROVE TREATMENT OF LIVER CANCER

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

Position Description Ovarian Cancer Australia Support Coordinator, Support Programs

Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology MD Anderson Cancer Center Houston, Texas USA

MOVEMBER FOUNDATION PRESS KIT

Patrons. For further information please visit

International collaboration to develop inhaled form of oxytocin to manage bleeding after childbirth in developing countries

Deceased donation data in the UK. Paul Murphy National Clinical Lead for Organ Donation United Kingdom

Summary Transforming healthcare for women and newborns

British Association of Stroke Physicians Strategy 2017 to 2020

Authors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS).

Fast-Forwarding a Cure for Melanoma

RESEARCH EDUCATION COMMUNITY STRATEGIC PLAN

All about interrai. Len Gray Coordinator, interrai Network of Excellence in Acute Care April

Wednesday 8 March Behaviours of concern following traumatic brain injury Presenters:

Mr. Kevin Dwan. The Sabrina Foundation Center for Cardiovascular Health in Pregnancy

VISION» FOCUS DISCOVERY» CREATION

DIVISION OF NEPHROLOGY

UC HEALTH RESEARCH INSTITUTE STRATEGIC PLAN

Melanoma. Research Alliance. Fast-Forwarding a Cure for Deadly Skin Cancer

Financial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment

WHAT ARE ISN GLOBAL OUTREACH PROGRAMS?

THE CANADA-ISRAEL TRANS-ATLANTIC COLLABORATION FOR BRAIN STUDIES

May 23, Dear Friends of Rugiero Promise Foundation,

How have you contributed to Cochrane s work during your time as a member?

HIGHER DEGREE RESEARCH

THE ALAN COOPER EPIDERM LECTURE

I. CHESTER COUNTY COMMUNITY FOUNDATION GRANT PROPOSAL SUMMARY SHEET Date September 20, 2018

Promotion of Regulatory Cooperation Perspectives from the International Regulatory Cooperation for Herbal Medicines (IRCH)

SEWF SEPTEMBER 2018 EDINBURGH, SCOTLAND

Momentous gathering of the dental industry DenTech China 2017 The 21 st China International Exhibition & Symposium on Dental Equipment, Technology &

Infectious Disease Testing. ULTRA Product Line. Safety is not a Matter of Chance

Cardiology and Heart Diseases November 5-6, 2018 Amsterdam, Netherlands

Jeff Balser, M.D., Ph.D., President and CEO of Vanderbilt University Medical Center, and Dean, Vanderbilt University School of Medicine.

SAVING LIVES: ACHIEVING MORE

The Quit Clinic As an Anti-smoking Advocacy Tool

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

For personal use only

Children s Cancer Institute Strategic Plan It s not if. It s when. STRATEGIC PLAN

Joint Programming in Neurodegenerative Disease Research (JPND)

Global EHS Resource Center

Memory Research Suite

Main developments in past 24 hours

CREATING GLOBALLY CONNECTED LEADERS AN INVITATION TO JOIN HRH THE PRINCESS ROYAL, PRINCESS ANNE

So begins a report in the May 5, 2003, issue of the Archives of Physical Medicine* that concludes:

Who we are. We envision a world where high quality eye health and vision care is accessible to all people.

GOTHENBURG April Sponsorship & Exhibition Opportunities

Cracking the cancer code. John van Geest Cancer Research Centre

Transcription:

AUSTRALIA S FIRST DEDICATED DEPARTMENT OF DIABETES med.monash.edu/cecs/diabetes

2 MONASH UNIVERSITY DEPARTMENT OF DIABETES

AT A GLANCE FAST FACTS WHO WE ARE Monash University s Department of Diabetes is the first and only university department in Australia specifically focusing on diabetes. Established in early 2017, we are located within the Central Clinical School of the Faculty of Medicine, Nursing and Health Sciences a leading provider of healthcare education and research in Australia. With more than 60 scientists and students involved across 10 critical areas of diabetes research, our clinical research takes a bench to bedside approach to directly improve outcomes for patients. This integrated way of solving this major global health challenge is due to our strong collaborations with healthcare providers. These local, national and international partnerships give us the opportunity to work closely with clinicians and patients to translate findings from the lab into clinical trials or treatments that will have tangible health benefits for people and communities. WHAT WE DO Diabetes is an exploding epidemic and the biggest challenge confronting Australia s health system. Around 1.7 million Australians have diabetes, with 280 Australians developing the disease every day. This makes it the fastest growing chronic condition in the country. In 2013, diabetes caused 5.1 million deaths globally. One of the major objectives of the department is the clinical translation of research findings to benefit patients. Nurture young research talent through mentoring during PhD projects Our team is working on diverse strategies from dietary intervention to new pharmacological approaches to combat diabetes and its complications; the three most significant of which are kidney disease, heart disease and blindness. 60 RESEARCHERS 10 CRITICAL AREAS 50 CURRENT AND COMPLETED PHD STUDENTS 576 PUBLICATIONS Drs Mark Ziemann and Ishant Khurana setting up genetic samples for analysis. MONASH UNIVERSITY DEPARTMENT OF DIABETES 3

OUR IMPACT EXCEPTIONAL RESEARCH, GLOBAL LEADERS We are led by two internationally renowned diabetes specialists, Professor Mark Cooper AO and Professor Paul Zimmet AO, working with a team of talented and dedicated researchers. For more information about our team, please visit our website: med.monash.edu/cecs/diabetes 4 MONASH UNIVERSITY DEPARTMENT OF DIABETES Professor Paul Zimmet AO Professor Mark Cooper AO

OUR CASE STUDIES DIABETES FACTS ACE INHIBITORS SLOW DOWN KIDNEY DISEASE Professor Mark Cooper s groundbreaking research from the 1980s identified enzymes (angiotensin-converting-enzyme [ACE] inhibitors and angiotensin II receptor blockers [ARB]) that decrease the amount of protein in the urine, which in turn slow or even prevent the progression to diabetes-related kidney disease. The research was sufficiently promising to progress it through pre-clinical trials, then human trials, and the findings have been widely incorporated into medications and treatment protocols around the world. USING NOX ENZYMES TO COMBAT KIDNEY AND HEART DISEASE Innovative research by Monash scientists has progressed to clinical trials in humans for the treatment of kidney disease. Professor Karin Jandeleit-Dahm and her team have shown that an enzyme known as a NOX inhibitor, reduced inflammation and could even reverse complications which had already progressed in diabetic patients. The results using the novel NOX inhibitor in diabetic nephropathy will form the basis of clinical trials later this year at the Alfred campus. 1.7M MILLION AUSTRALIANS DIAGNOSED WITH DIABETES 5.1M MILLION DEATHS GLOBALLY $ 1/9 HEALTH DOLLARS IS SPENT ON DIABETES $1TN ESTIMATED TO RISE PAST ONE TRILLION DOLLARS (AUD) PER ANNUM WORLDWIDE (International Diabetes Foundation) Dr Tom Karagiannis with his Epigenomic Medicine group. Dr Jay Jha, NHMRC Early Career Fellow in Professor Karin Jandeleit-Dahm s group, who works on cell surface enzymes. MONASH UNIVERSITY DEPARTMENT OF DIABETES 5

OUR NETWORK COLLABORATING AND CONNECTING WITH THE BEST IN THE WORLD /GLOBAL PARTNERSHIPS Our research leaders have an outstanding international reputation and are active in extensive research collaborations with leading scientists and institutions around the world. These have included recent collaborations with two major institutions in Tel Aviv (Tel Aviv Sourasky Medical Center and the University of Tel Aviv), Bar-Ilan University and University College Dublin. PARTNERING WITH US Our vision is for a world where the incidence of diabetes is shrinking, not growing, and where there are effective and affordable treatments available to all affected by the disease. Achieving this aim requires a coordinated approach and the support of many to ensure our cutting-edge research can be successfully translated into medical practice. Through the support of our generous donors we have been able to support our young scientists with their research fellowships, purchase the latest equipment and technologies to ensure we remain at the forefront of global diabetes research, and allow us to contribute to the crucial commercialisation of our team s key research findings so they reach patients sooner. We are extremely grateful for the significant donations of the Meydan and Jreissati families who have helped to establish this Australian first dedicated Department of Diabetes for Monash University. MONASH UNIVERSITY DEPARTMENT OF DIABETES INTERNATIONAL COLLABORATIONS 6 MONASH UNIVERSITY DEPARTMENT OF DIABETES

ENGAGING WITH THE WIDER COMMUNITY We share our diabetes research and treatment achievements through: Clinical treatment of diabetic patients Professional education of medical practitioners who work with diabetic patients Open days, discovery tours and public lectures Publication of research discoveries through peer reviewed journals. THE FALL IN MORTALITY FROM DIABETES IS LIKELY TO BE ONE OF THE GREATEST SUCCESS STORIES IN MEDICINE SINCE VACCINES. Professor Paul Zimmet Honorary President of the International Diabetes Federation AUSTRALIA 2 MALAYSIA 1 CANADA 4 MAURITIUS 1 CHINA 2 NETHERLANDS 2 DENMARK 1 NEW ZEALAND 1 FINLAND 3 SCOTLAND 2 GERMANY 4 SINGAPORE 2 HONG KONG 2 SWEDEN 2 IRELAND 3 UAE 1 ISRAEL 3 UNITED KINGDOM 3 JAPAN 1 UNITED STATES 9 MONASH UNIVERSITY VICTORIAN DEPARTMENT HEART OF DIABETES HOSPITAL 7

FURTHER INFORMATION Contact us Whether you want to research, invest, study or partner with us, we d be delighted to hear from you. Monash University Department of Diabetes Level 5, Alfred Centre 99 Commercial Road Melbourne, Victoria 3004 T: +61 3 9903 0009 E: MED-Diabetesadmin@monash.edu med.monash.edu/cecs/diabetes All information is correct at time of printing. CRICOS provider: Monash University 00008C. Designed by SMC, Monash University 17P-0900. August 2017. VICTORIAN HEART HOSPITAL 1